20278 results for «»
20278 results
Maria Del Trigo Espinosa
Majadahonda, Spain
Raquel Del Valle
Oviedo, Spain
Marc Dweck
Edinburgh, United Kingdom
Covadonga Fernández-Golfín
Madrid, Spain
Guosheng Fu
Hangzhou, China
TRISCEND Six-Month Outcomes of Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation
07 Nov 2021
Alessandro Sticchi interviews Susheel Kodali, PI of the TRISCEND trial, presented at TCT 2021. They discuss the main results of the study, its impact on the field of Tricuspid and the upcoming TRISCEND II study.
Author
Author
Successful Stent-less Percutaneous Coronary Intervention of Chronic Total Occlusion by Ablation Devices in a Young Adult
04 Nov 2021
View this case with a 38-year-old male with effort angina and chronic total occlusion at the ostial segment of the left anterior descending artery.
Francesco Spione
Barcelona, Spain
Impact of intravascular ultrasound on long-term clinical outcomes in patients with acute myocardial infarction
04 Nov 2021
There are limited data evaluating long-term outcomes of IVUS use in patients with acute myocardial infarction (AMI). The aim of this study was to examine the impact of IVUS-guided PCI on long-term clinical outcomes in patients with AMI.
Reviewer
Reviewer
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR
28 Oct 2021
To further investigate the treatment effects of ticagrelor monotherapy compared with ticagrelor plus aspirin in a contemporary HBR population, a pre-specified analysis of the TWILIGHT trial, TWILIGHT-HBR, was conducted by using the Academic Research Consortium (ARC) criteria for HBR.
Reviewer
Reviewer
Elif Ilkay Yuce
Gaziantep, Türkiye
Thijmen Hokken
Rotterdam, Netherlands
Fractional flow reserve to guide treatment of patients with multivessel coronary artery disease - the FUTURE trial
05 Nov 2021
The FUTURE Trial is a prospective randomised, multicentre, open label superiority trial comparing an FFR guided treatment strategy to traditional angiography guided treatment strategy on clinical outcomes in an all-comer population with multivessel coronary artery disease.
Reviewer
Digital coverage of PCR London Valves 2024
Best of #AHA21 Scientific Sessions: coronary and valvular heart disease trials
14 Nov 2021
Vijay Kunadian provides summaries of study designs and findings in Interventional Cardiology released at the 2021 virtual edition of the American Heart Association Congress. View an infographic of the AVATAR late-breaking trial by Ali Nazmi Calik.
Author
PCR London Valves 2021 - VOD Programme
Johanna Vogelhuber
Bonn, Germany
PCR London Valves 2021 - Training Programme
Filter the Interactive Programme to view what’s taking place in the on-site Training Village, and what’s on offer in the Online Training Workshops.
Hurry to secure a virtual seat for those online, as space is limited*. Just click "Sign Up" and you’ll be taken to the corresponding Industry Partner’s...
Rivaroxaban monotherapy in patients with atrial fibrillation after coronary stenting: insights from the AFIRE trial
08 Nov 2021
In this prespecified subgroup analysis of the AFIRE trial, the authors report the outcomes of rivaroxaban monotherapy compared to rivaroxaban and an antiplatelet agent in patients with atrial fibrillation who underwent coronary stenting > 1 year prior to enrolment.
Reviewer
Transcatheter tricuspid valve interventions
01 Jul 2025
Several transcatheter tricuspid valve therapies are available to address different targets, including leaflet approximation, annuloplasty, valve replacement, valve-in-valve implantation and heterotopic valve implantation. Such devices and their initial promising evidences are reviewed in this up-to-date chapter!
Authors :
